Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that more research is needed to better understand and treat primary cicatricial alopecias, and suggests a possible reclassification based on molecular pathways.

Patients with certain skin symptoms and high ANA titers should be monitored for potential systemic lupus.

Most people with systemic lupus erythematosus have skin problems, and skin symptoms are often the first sign of the disease.

Transplant success has improved with better immunosuppressive drugs and donor matching.

Human dermal fibroblasts are the main cells targeted by a virus that can cause a deadly skin cancer, and a certain inhibitor can effectively block this infection.

Early detection and intensive treatment of diseases caused by Staphylococcus aureus toxins are crucial for reducing severe health effects.

Low doses of some substances can be beneficial, while high doses can be harmful or toxic.

The document describes how to tell different types of non-scarring hair loss apart by looking at hair and scalp tissue under a microscope.

No single treatment is consistently effective for alopecia areata, and more research is needed.

Flutamide rarely causes liver toxicity in prostate cancer patients.

COVID-19 can cause skin issues like rashes and "COVID toes," and people with skin conditions should adjust their treatments if they get the virus.

Voriconazole can cause serious side effects, especially in long-term use.

New treatments for Alopecia Areata show promise but need to be more effective and affordable.

Dutasteride may help stabilize Frontal Fibrosing Alopecia, but more research is needed.

There are many treatments for permanent hair loss disorders, but their effectiveness varies and there's no clear best option.

Mutations in the PADI3 gene are linked to a higher risk of scarring hair loss in women of African descent.

The document concludes that accurate diagnosis of different types of hair loss requires careful examination of hair and scalp tissue, considering both clinical and microscopic features.

The document concludes that understanding the genes and pathways involved in hair growth is crucial for developing treatments for hair diseases.

Alopecia areata is likely caused by a combination of genetic factors and immune system dysfunction, and may represent different diseases with various causes.

Mice studies show that Protein Phosphatase 2A is crucial for cell growth, development, and disease prevention.

Cancer patients treated with immune checkpoint inhibitors may develop alopecia, but some hair regrowth is possible with treatment.

Alopecia Areata is an autoimmune condition often starting before age 20, with varied treatment success and a need for personalized treatment plans.

The document concludes that rapid identification, isolation, and strict infection control are crucial to manage SARS outbreaks.

Hair loss that spreads out can often fix itself or be treated by finding and handling the cause.

Environmental factors, hormones, nutrition, and stress all significantly affect skin health and aging.

CCCA is a hair loss type affecting African women, possibly caused by grooming and chemicals, with various treatments and needing more research.

Toxic epidermal necrolysis is a severe skin condition often caused by drugs, with complex treatment and a high risk of death, but survivors usually heal without scars.

Some women with common hair loss may develop permanent hair loss.

Oral dutasteride and topical pimecrolimus can safely and effectively treat Frontal Fibrosing Alopecia, leading to significant hair regrowth.

Skin problems are very common in people with end-stage kidney disease.